Assembly Biosciences (ASMB) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Apr, 2026Executive summary
Annual meeting scheduled for June 4, 2026, with virtual participation available for shareholders.
Shareholders are encouraged to review proxy materials and vote by June 3, 2026.
Voting matters and shareholder proposals
Election of nine directors is proposed, with all nominees recommended by the board.
Advisory vote on executive compensation (say-on-pay) is included.
Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.
Proposal to amend the 2018 Stock Incentive Plan to increase shares reserved by 1,200,000.
Proposal to amend the 2018 Employee Stock Purchase Plan to increase authorized shares to 515,000.
Board of directors and corporate governance
Board recommends all director nominees for election at the annual meeting.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Assembly Biosciences
- Advancing late-stage antiviral therapies with strong data and Gilead partnership for major unmet needs.ASMB
Corporate presentation - Collaboration revenue up 39%, net loss narrowed, and $115M financing supports key trials ahead.ASMB
Q2 2026 - Strong clinical data and strategic partnerships set up major catalysts from 2027 to 2028.ASMB
Goldman Sachs 47th Annual Global Healthcare Conference 2026 - All board nominees and proposals were approved, with no shareholder questions raised.ASMB
AGM 2026 - Key clinical milestones and expansion into new liver disease indications drive near- and long-term catalysts.ASMB
Jefferies Global Healthcare Conference 2026 - Advancing oral antivirals for HSV and hepatitis D, targeting unmet needs with strong early data.ASMB
Bank of America Global Healthcare Conference 2026 - Long-acting antivirals for herpes and hepatitis advance with strong efficacy, safety, and Gilead partnership.ASMB
Corporate presentation - Gilead exercised its HPI option, $35M paid, $9.1M net loss, and strong cash reserves maintained.ASMB
Q1 2026 - Board recommends approval of all annual meeting proposals, including equity plan amendments.ASMB
Proxy filing